These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34636081)

  • 41. Applications of general multistage gatekeeping and graphical multiple testing strategies in a clinical trial setting.
    Li Y; Wang X; Wang D; Offen W
    Contemp Clin Trials; 2019 Jan; 76():9-15. PubMed ID: 30343046
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Bayesian sequential design using alpha spending function to control type I error.
    Zhu H; Yu Q
    Stat Methods Med Res; 2017 Oct; 26(5):2184-2196. PubMed ID: 26187736
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A simple and flexible Holm gatekeeping procedure.
    Li J
    Biom J; 2011 Sep; 53(5):797-809. PubMed ID: 21887794
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A step-up test procedure to find the minimum effective dose.
    Wang W; Peng J
    J Biopharm Stat; 2015; 25(3):525-38. PubMed ID: 24905396
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A computer program for designing clinical trials with arbitrary survival curves and group sequential testing.
    Halpern J; Brown BW
    Control Clin Trials; 1993 Apr; 14(2):109-22. PubMed ID: 8500301
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Validity of the Hochberg procedure revisited for clinical trial applications.
    Huque MF
    Stat Med; 2016 Jan; 35(1):5-20. PubMed ID: 26278421
    [TBL] [Abstract][Full Text] [Related]  

  • 47. General multistage gatekeeping procedures.
    Dmitrienko A; Tamhane AC; Wiens BL
    Biom J; 2008 Oct; 50(5):667-77. PubMed ID: 18932130
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Some new multiple-test procedures for dose finding.
    Dunnett CW; Tamhane AC
    J Biopharm Stat; 1998 Jul; 8(3):353-66. PubMed ID: 9741852
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of the spending function method and the Christmas tree correction for group sequential trials.
    Stallard N; Facey KM
    J Biopharm Stat; 1996 Jul; 6(3):361-73. PubMed ID: 8854238
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multiple testing procedures in two pivotal clinical trials for approval of a new pharmaceutical product.
    Wiens BL
    J Biopharm Stat; 2011 Jul; 21(4):669-81. PubMed ID: 21516563
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Confidence intervals following group sequential tests in clinical trials.
    Kim K; DeMets DL
    Biometrics; 1987 Dec; 43(4):857-64. PubMed ID: 3427170
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
    Lewis RJ; Lipsky AM; Berry DA
    Clin Trials; 2007; 4(1):5-14. PubMed ID: 17327241
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Simultaneous confidence regions for closed tests, including Holm-, Hochberg-, and Hommel-related procedures.
    Guilbaud O
    Biom J; 2012 May; 54(3):317-42. PubMed ID: 22685000
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adaptive extensions of a two-stage group sequential procedure for testing primary and secondary endpoints (II): sample size re-estimation.
    Tamhane AC; Wu Y; Mehta CR
    Stat Med; 2012 Aug; 31(19):2041-54. PubMed ID: 22733687
    [TBL] [Abstract][Full Text] [Related]  

  • 55. On testing simultaneously non-inferiority in two multiple primary endpoints and superiority in at least one of them.
    Röhmel J; Gerlinger C; Benda N; Läuter J
    Biom J; 2006 Dec; 48(6):916-33. PubMed ID: 17240652
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The fallback procedure for evaluating a single family of hypotheses.
    Wiens BL; Dmitrienko A
    J Biopharm Stat; 2005; 15(6):929-42. PubMed ID: 16279352
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A general formulation for a one-sided group sequential design.
    Moser BK; George SL
    Clin Trials; 2005; 2(6):519-28. PubMed ID: 16422312
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Properties of multiple intersection-union tests for multiple endpoints in combination therapy trials.
    Westfall PH; Ho SY; Prillaman BA
    J Biopharm Stat; 2001; 11(3):125-38. PubMed ID: 11725927
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Selection of hypothesis weights and ordering when testing multiple hypotheses in clinical trials.
    Wiens BL; Dmitrienko A; Marchenko O
    J Biopharm Stat; 2013; 23(6):1403-19. PubMed ID: 24138439
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Familywise error control in multi-armed response-adaptive trials.
    Robertson DS; Wason JMS
    Biometrics; 2019 Sep; 75(3):885-894. PubMed ID: 30714095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.